National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting, 8963-8964 [E9-4204]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 38 / Friday, February 27, 2009 / Notices
Dated: February 3, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–4190 Filed 2–26–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Extension of
the World Trade Center Registry (U50),
Request for Applications (RFA) OH–
09–002
rwilkins on PROD1PC63 with NOTICES2
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 8 a.m.–5 p.m., March
31, 2009 (Closed).
Place: Embassy Suites Hotel, 1900
Diagonal Road, Alexandria, Virginia
22314.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the review, discussion, and
evaluation of ‘‘Extension of the World
Trade Center Registry (U50), RFA OH–
09–002.’’
For Further Information Contact: M.
Chris Langub, Ph.D., Scientific Review
Officer, Office of Extramural Programs,
CDC, 1600 Clifton Road, NE., Mailstop
E74, Atlanta, Georgia, Telephone:
(404)498–2543.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: February 19, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–4195 Filed 2–26–09; 8:45 am]
BILLING CODE 4163–18–P
VerDate Nov<24>2008
16:39 Feb 26, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Assessing the
Accuracy of Self-Report of HIV Testing
Behavior, Program Announcement
Number (PA) 09–002
Correction: This notice was published
in the Federal Register on February 10,
2009, Volume 74, Number 26, Page
6634. The place and time should read as
follows:
Time and Date: 12 p.m.–3 p.m.,
March 20, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: February 13, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–4210 Filed 2–26–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff,
Announces the Following Meeting
Name: ICD–9–CM Coordination and
Maintenance Committee meeting.
Time and Date: 8:30 a.m.–4:30 p.m.,
March 11–12, 2009.
Place: Centers for Medicare and
Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore,
Maryland.
Status: Open to the public.
Purpose: The ICD–9–CM Coordination
and Maintenance (C&M) Committee will
hold its first meeting of the 2009
calendar year cycle on Wednesday and
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
8963
Thursday March 11–12, 2009. The C&M
meeting is a public forum for the
presentation of proposed modifications
to the International Classification of
Diseases, Ninth-Revision, Clinical
Modification.
Matters to be Discussed: Tentative
agenda items include: Body Mass Index
(BMI) 50 and over Cognitive symptoms
related to Traumatic Brain Injury (TBI)
and other eurological conditions, E. coli
expansion fecal incontinence 5th digits
for epilepsy codes, Heart failure,
Mullerian anomalies personal history of
Vulvar Intraepithelial Neoplasia (VIN)
and Vaginal Intraepithelial Neoplasia
(VAIN)Addenda (diagnoses), Injection
of chemotherapeutic agent Intravascular
optical coherence tomography (OCT),
Thoracoscopic procedures, Virtual
histology intravascular ultrasound (VH–
IVUS), Addenda (procedures), and ICD–
10/MS–DRG update.
For Further Information Contact: Amy
Blum, Medical Systems Specialist,
Classifications and Public Health Data
Standards Staff, NCHS, 3311 Toledo
Road, Room 2402, Hyattsville, Maryland
20782, e-mail alb8@cdc.gov, telephone
301–458–4106 (diagnosis), Mady Hue,
Health Insurance Specialist, Division of
Acute Care, CMS, 7500 Security Blvd.,
Baltimore, Maryland 21244, e-mail
marilu.hue@cms.hhs.gov, telephone
410–786–4510 (procedures).
Notice: Because of increased security
requirements CMS has instituted
stringent procedures for entrance into
the building by non-government
employees. Persons without a
government I.D. will need to show an
official form of picture I.D., (such as a
drivers license), and sign-in at the
security desk upon entering the
building.
Those who wish to attend a specific
ICD–9–CM C&M meeting in the CMS
auditorium must submit their name and
organization for addition to the meeting
visitor list. Those wishing to attend the
March 11–12, 2009 meeting must
submit their name and organization by
March 5, 2009 for inclusion on the
visitor list. This visitor list will be
maintained at the front desk of the CMS
building and used by the guards to
admit visitors to the meeting. Those
who attended previous ICD–9–CM C&M
meetings will no longer be
automatically added to the visitor list.
You must request inclusion of your
name prior to each meeting you attend.
Register to attend the meeting on-line
at: https://www.cms.hhs.gov/apps/
events/.
Notice: This is a public meeting.
However, because of fire code
requirements, should the number of
E:\FR\FM\27FEN1.SGM
27FEN1
8964
Federal Register / Vol. 74, No. 38 / Friday, February 27, 2009 / Notices
attendants meet the capacity of the
room, the meeting will be closed.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: February 13, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E9–4204 Filed 2–26–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10237 and
10214, and CMS–10171]
rwilkins on PROD1PC63 with NOTICES2
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare
Advantage Applications—Part C and
regulations under 42 CFR part 422
subpart K; Use: The Balanced Budget
Act of 1997 established a new ‘‘Part C’’
in the Medicare statute Social Security
Act (the Act), which provided for a
Medicare+Choice (M+C) program.
Under section 1851 of the Act, every
individual entitled to Medicare Part A
VerDate Nov<24>2008
16:39 Feb 26, 2009
Jkt 217001
and enrolled under Part B, except for
most individuals with end-stage renal
disease (ESRD), could elect to receive
benefits either through the Original
Medicare Program or an M+C plan.
The Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) was enacted on December
8, 2003. The MMA established the
Medicare Prescription Drug Benefit
Program (Part D) and made revisions to
the provisions of Medicare Part C,
governing what is now called the
Medicare Advantage (MA) program
(formerly Medicare+Choice).
Coverage for the prescription drug
benefit is provided through contracted
prescription drug plans or through
Medicare Advantage (MA) plans that
offer integrated prescription drug and
health care coverage (MA–PD plans).
Cost plans that are required under
section 1876 of the Social Security Act,
and Employer Group Waiver Plans
(EGWP) may also provide a Part D
benefit. Organizations wishing to
provide services under the MA and
MA–PD plans must complete an
application, negotiate rates and receive
final approval from CMS. Certain
existing MA plans may also expand
their contracted area by completing the
Service Area Expansion (SAE)
application.
Form Number: CMS–10237 and 10214
(OMB# 0938–0935); Frequency: Yearly;
Affected Public: Private Sector; Number
of Respondents: 267; Total Annual
Responses: 267; Total Annual Hours:
6,490. (For policy questions regarding
this collection contact Betty Burrier at
410–786–4649. For all other issues call
410–786–1326.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Coordination of
Benefits between Part D Plans and Other
Prescription Coverage Providers; Use:
Section 1860D–23 and 1860D–24 of the
Social Security Act requires the
Secretary to establish requirements for
prescription drug plans to ensure the
effective coordination between Part D
plans, State pharmaceutical Assistance
programs and other payers. This
collection request will assist CMS, Part
D plans and other payers with
coordination of prescription drug
benefits at the point-of-sale and tracking
of the beneficiary’s True out-of-pocket
(TrOOP) expenditures using the TrOOP
facilitator. This information will be used
by Part D plans, other health insurers or
payers, pharmacies and CMS to
coordinate prescription drug benefits
provided to the Medicare beneficiary.
Beginning in CY 2009, CMS, via the
TrOOP facilitation contractor, will
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
automate the transfer of beneficiary
coverage information when a
beneficiary changes plans. Form
Number: CMS–10171 (OMB# 0938–
0978); Frequency: Hourly, yearly and
occasionally; Affected Public: Business
or other for-profits; Number of
Respondents: 56,988; Total Annual
Responses: 1,139,760; Total Annual
Hours: 1,125,883. (For policy questions
regarding this collection contact
Christine Hinds at 410–786–4578. For
all other issues call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web site
at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by April 28, 2009:
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number, Room C4–26–05, 7500
Security Boulevard, Baltimore,
Maryland 21244–1850.
Dated: February 20, 2009.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E9–4128 Filed 2–26–09; 8:45 am]
BILLING CODE 4120–01–P
E:\FR\FM\27FEN1.SGM
27FEN1
]]>Agencies
[Federal Register Volume 74, Number 38 (Friday, February 27, 2009)]
[Notices]
[Pages 8963-8964]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-4204]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Health Statistics (NCHS), Classifications and
Public Health Data Standards Staff, Announces the Following Meeting
Name: ICD-9-CM Coordination and Maintenance Committee meeting.
Time and Date: 8:30 a.m.-4:30 p.m., March 11-12, 2009.
Place: Centers for Medicare and Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore, Maryland.
Status: Open to the public.
Purpose: The ICD-9-CM Coordination and Maintenance (C&M) Committee
will hold its first meeting of the 2009 calendar year cycle on
Wednesday and Thursday March 11-12, 2009. The C&M meeting is a public
forum for the presentation of proposed modifications to the
International Classification of Diseases, Ninth-Revision, Clinical
Modification.
Matters to be Discussed: Tentative agenda items include: Body Mass
Index (BMI) 50 and over Cognitive symptoms related to Traumatic Brain
Injury (TBI) and other eurological conditions, E. coli expansion fecal
incontinence 5th digits for epilepsy codes, Heart failure, Mullerian
anomalies personal history of Vulvar Intraepithelial Neoplasia (VIN)
and Vaginal Intraepithelial Neoplasia (VAIN)Addenda (diagnoses),
Injection of chemotherapeutic agent Intravascular optical coherence
tomography (OCT), Thoracoscopic procedures, Virtual histology
intravascular ultrasound (VH-IVUS), Addenda (procedures), and ICD-10/
MS-DRG update.
For Further Information Contact: Amy Blum, Medical Systems
Specialist, Classifications and Public Health Data Standards Staff,
NCHS, 3311 Toledo Road, Room 2402, Hyattsville, Maryland 20782, e-mail
alb8@cdc.gov, telephone 301-458-4106 (diagnosis), Mady Hue, Health
Insurance Specialist, Division of Acute Care, CMS, 7500 Security Blvd.,
Baltimore, Maryland 21244, e-mail marilu.hue@cms.hhs.gov, telephone
410-786-4510 (procedures).
Notice: Because of increased security requirements CMS has
instituted stringent procedures for entrance into the building by non-
government employees. Persons without a government I.D. will need to
show an official form of picture I.D., (such as a drivers license), and
sign-in at the security desk upon entering the building.
Those who wish to attend a specific ICD-9-CM C&M meeting in the CMS
auditorium must submit their name and organization for addition to the
meeting visitor list. Those wishing to attend the March 11-12, 2009
meeting must submit their name and organization by March 5, 2009 for
inclusion on the visitor list. This visitor list will be maintained at
the front desk of the CMS building and used by the guards to admit
visitors to the meeting. Those who attended previous ICD-9-CM C&M
meetings will no longer be automatically added to the visitor list. You
must request inclusion of your name prior to each meeting you attend.
Register to attend the meeting on-line at: https://www.cms.hhs.gov/
apps/events/.
Notice: This is a public meeting. However, because of fire code
requirements, should the number of
[[Page 8964]]
attendants meet the capacity of the room, the meeting will be closed.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: February 13, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. E9-4204 Filed 2-26-09; 8:45 am]
BILLING CODE 4163-18-P
